摘要
西妥昔单抗是特异性针对表皮生长因子受体（ epidermal growth factor receptor, EGFR）的单克隆抗体，临床研究表明该药无论是单药还是与化疗药物联合使用，均可提高晚期结直肠癌K-Ras野生型患者的疗效，毒副反应可耐受。我们在临床治疗中收治1例西妥昔单抗引起的肾病综合征患者，现报告如下。
出处
《临床肿瘤学杂志》
CAS
2013年第8期766-767,共2页
Chinese Clinical Oncology
参考文献10
-
1Cunningham D, Humbler Y, Siena S, et al. Cetuximab mono- therapy and cetuximab plus irinotecan in irinotecan-refractory me- tastatic colorectal cancer [ J ]. N Engl J Med, 2004,351 (4) :337 - 345.
-
2Jonker D J, O'Callaghan C, Karapetis CS, et al. Cetuximah for the Treatment of Colorectal Cancer[J]. N Engl J Med,2007,357 (20) :2040 - 2048.
-
3Van Cntsem E, Kohne CH, Hitre E, et al. Cetuximab and chem- otherapy as initial treatment for metastatic colorectal cancer [ J ]. N Engl J Med,2009,360(14) :1408 -1417.
-
4Bokemeyer C, Bondarenko I, Makhson A, et al. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer[J]. J Clin On- col,2009,27 ( 5 ) :663 - 671.
-
5Bokemeyer C, Van Cutsem E, Rougier P, et al. Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild- type metastatic colorectal cancer: pooled analysis of the CRYS- TAL and OPUS randomised clinical trials [ J ]. Eur J Cancer, 2012,48 (10) : 1466 - 1475.
-
6National Comprehensive Cancer Network. National Comprehensive Cancer Network(NCCN) Clinical Practice Guidelines in Oncolo- gy. Colon Cancer. Version 3 [ EB/OL. 2012 [ 2013-05-20 ]. ht- tp://www, nccn. org/patients/patient_guidelines/eolort/index. html#/8/.
-
7Fuloria J. Safety profiles of current antiangiogenic therapies for metastatic eolorectal cancer[ J1.Onco Targets Ther, 2012,5:133 - 142.
-
8ho C, Fujii H, Ogura M, et al. Cetuximab-induced nephrotic syndrome in a case of metastatic rectal cancer[ J/OL]. J Oncol Pharm Pract, 2012 [ 2013435-20 ]. http ://www. ncbi. nlm. nih. gov/pubmed/23047237.
-
9Sasaki K, Anderson E, Shankland S J, et al. Diffuse proliferative glomerulonephritis associated with cetuximab, an epidermal growth factor receptor inhibitor [ J ]. Am J Kidney Dis, 2013,61 (6) :988 -991.
-
10Kes P, Basic-Jukic N, Ljutic D, et al. The role of arterial hyper- tension in developement of chronic renal failure [ J ]. Acta Med Croatica,2011,65 ( Suppl 3 ) :78 - 84.
同被引文献46
-
1王源,程绍钧.^(131)Ⅰ-KDR单克隆抗体抑制荷人膀胱癌SCID小鼠瘤体生长的实验研究[J].第三军医大学学报,2004,26(14):1235-1238. 被引量：1
-
2黄慧强,蔡清清.利妥昔单抗治疗恶性淋巴瘤的进展[J].中国新药杂志,2006,15(21):1883-1888. 被引量：2
-
3赵玉沛.胰腺癌诊治存在的问题与争议[J].中华消化外科杂志,2007,6(4):249-251. 被引量：18
-
4张一桥.赫赛汀联合紫杉醇治疗Her-2过度表达的转移性乳腺癌22例疗效观察[J].山东医药,2007,47(34):106-107. 被引量：5
-
5熊建萍,冯苗.西妥昔单抗在消化系肿瘤中的研究及应用[C].//中国临床肿瘤学教育专辑(2007).2007:360.364.
-
6Agulnik M. New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SC- CHN) [J]. Med Oncol, 2012, 29 (4) : 2481-2491.
-
7Hynes NE, Horsch K, Olayioye MA, et al. The ErbB receptor tyrosinefamily as signal integrators [J]. Endocr Relat Cancer, 2001,8: 151- 159.
-
8Rocha-Lima CM, Soares HP, Raez LE, et al. EGFR targeting of solid tumors [j]. Cancer Control, 2007, 14: 295-304.
-
9Kruger JS, Reddy KB. Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor recep- tor-overexpressing cells [Jl. Mol Cancer Res, 2003,1:801-809.
-
10Vivanco I,Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancerFJ]. Nat Rev Cancer, 2002, 2: 489-501.
引证文献3
-
1潘博宇,王荷花,陈孝平.单克隆抗体治疗恶性肿瘤的临床应用进展[J].临床误诊误治,2014,27(10):110-113. 被引量：3
-
2刘得玺,牛玉明,罗志晓,冷卫东.西妥昔治疗头颈部鳞癌的研究进展[J].临床口腔医学杂志,2015,31(11):702-703.
-
3晏子俊,张良明,朱江红,陈彦清,袁晓燕,王璇.西妥昔单抗致肾病综合征1例[J].中国药师,2019,22(9):1690-1691.
二级引证文献3
-
1季发和,朴瑛,谢晓冬,郑振东.贝伐珠单抗联合化疗致下肢深静脉血栓形成一例并文献复习[J].临床误诊误治,2016,29(12):7-9. 被引量：5
-
2王飞,李春红.贝伐珠单抗联合替莫唑胺治疗复发恶性脑胶质瘤的临床效果及安全性[J].中国医药,2018,13(10):1510-1513. 被引量：17
-
3沈晶,黄达永,魏娜,王晶石,杨凌志,王昭.利妥昔单抗治疗相关的间质性肺炎临床分析[J].中国医药,2020,15(7):1034-1037. 被引量：2
-
1朱文玉,乔中华,张晓梅,李靖,吕庆春,王立媛.以肾病综合征为临床表现的肺癌1例[J].中国肿瘤临床,2002,29(2):106-106. 被引量：1
-
2马红珍.多发性骨髓瘤与肾损害3例报道[J].浙江中西医结合杂志,1997,7(3):183-184.
-
3张树华,韩淑梅,吴淑华,郑国均,吴照敏.蛋白尿与胃癌生物学行为之间的关系[J].滨州医学院学报,1993,16(4):1-3.
-
4骨髓肿瘤[J].国外科技资料目录（医药卫生）,1998(10):129-129.
-
5牛书铭,朱光第.舌横纹肌肉瘤合并肾病综合征1例[J].实用口腔医学杂志,1994,10(2):148-149.
-
6佘明金,王强.卵巢癌合并肾病综合征一例[J].中华肿瘤杂志,2009,31(10):772-772.
-
7戴夕超,张西志,汪步海,袁一枫,王朝敏,张先稳,陈丽,蒋亚齐.贝伐单抗联合XELIRI方案治疗晚期结直肠癌临床观察[J].徐州医学院学报,2013,33(9):598-601. 被引量：1
-
8肖芹,顾学文,田秀春,王翠梅.p53和表皮生长因子受体在胃癌中的表达及其临床病理意义[J].实用肿瘤学杂志,2012,26(6):532-536. 被引量：5
-
9张晓雨,杨金云,平洪,周建农.结直肠癌表皮生长因子受体及survivin表达与生存期的相关性[J].中华实用诊断与治疗杂志,2012,26(6):552-553. 被引量：1
-
10赵爱国,李颖,夏天,苏如松.肾病综合征并发急性肾功能衰竭18例的病理特点与疗效观察[J].疑难病杂志,2009,8(1):43-44. 被引量：3
